Clinical Trial Update: iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009 [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update reports an early-phase 1 study to evaluate a novel mutant huntingtin PET radioligand labeled [11C]CHDI-00491009 for Huntington diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• [11C]CHDI-00491009 (Mutant huntingtin PET radioligand)

Snippet

Sponsor: CHDI Foundation, Inc. | Conditions: Huntington Disease, HD | EARLY_Phase 1 | Status: RECRUITING